Joseph Frattaroli

Chief Executive Officer, VASO ACTIVE PHARMACEUTICALS INC.

Companies

Inhibikase Therapeutics, Inc.Cheif Financial Officer Mar 9, 2022 to Mar 3, 2023¹
Inhibikase Therapeutics, Inc.Chief financial officer Dec 22, 2020 to May 23, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibikase Therapeutics, Inc. IKT92,234 shares³$145.3K at $1.57Mar 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 19, 2022Bought 3,948 shares at $0.64 of Inhibikase Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibikase Therapeutics, Inc., Cheif Financial Officer
2
SEC EDGARInhibikase Therapeutics, Inc., Chief financial officer
3
SEC EDGARInhibikase Therapeutics, Inc. shares after the filing of Mar 3, 2023
4
SEC EDGARForm 4 filed May 23, 2022